3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Rectal Neoplasms
5
Lung Neoplasms
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma Of Esophagus
4
Colonic Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms, Male
3
Brain Neoplasms
3
Sarcoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Breast Carcinoma In Situ
2
Vomiting
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Nausea
1
Medulloblastoma
1
Interventions
Ipilimumab
6
pembrolizumab
5
Nivolumab
5
Dacarbazine
5
CTLA-4 Antigen
4
Carboplatin
3
Bevacizumab
3
relatlimab
2
aflibercept
2
Temozolomide
2
Ranibizumab
2
Radiosurgery
2
Paclitaxel
2
Lenalidomide
2
Immunoglobulin G
2
Embolization, Therapeutic
2
Disulfides
2
Cyclophosphamide
2
Colony-Stimulating Factors
2
Albumin-Bound Paclitaxel
2
AZD 6244
2
130-nm albumin-bound paclitaxel
2
utomilumab
1
ulixertinib
1
trametinib
1
tebentafusp
1
sotrastaurin
1
sargramostim
1
poly ICLC
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uveal Melanoma
×
Chemotherapy, Adjuvant
×
Clear all
No trials found.